Oxycontin Maker Selling Opioid Addiction Drug, Too

Monday, Sept. 10, 2018 -- Purdue Pharma, the maker of Oxycontin who some have blamed for the epidemic of opioid painkiller addictions, has patented a medicine aimed at curbing those disorders.

OxyContin tablets should be taken at 12-hourly intervals. ... OxyContin is not intended for use as a prn analgesic. Increasing severity of pain will require an increased dosage of OxyContin tablets, using the 5 mg10 mg, 20 mg, 40 mg or 80 mg tablet strengths, either alone or in combination, to achieve pain relief.
Related image

The new anti-addiction drug is a fast-acting form of buprenorphine, which helps control drug cravings, CBS News reported. Previously prescribed in either tablet or fast-dissolving strips, the Purdue version comes in a "wafer" that dissolves in only a few seconds.

Richard Sackler, a member of Purdue's board, is listed as one of the inventors on the patent, CBS said. The Sackler family controls Purdue.

The announcement comes as Purdue finds itself in the middle of numerous lawsuits from states accusing the company of helping to create the opioid addiction crisis.
Related image

In one lawsuit, the Massachusetts attorney general accused Purdue of a "deadly, deceptive scheme to sell opioids." Purdue and the Sackler family deny the allegations.

Last week, Purdue donated $3.4 million to the developer of an over-the-counter version of naloxone, a drug often used to prevent a fatal opioid overdose. Purdue said it will not receive royalties from the new form of naloxone, which is being developed by Harm Reduction Therapeutics, CBS said.

Oxycontin Maker Selling Opioid Addiction Drug, Too
5 (100%) 45 vote[s]

Leave a Reply

Your email address will not be published. Required fields are marked *